242 related articles for article (PubMed ID: 35909146)
21. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
Martov AG; Ergakov DV
Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
[TBL] [Abstract][Full Text] [Related]
22. Effect of
Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
[No Abstract] [Full Text] [Related]
23. Androgen replacement in men undergoing treatment for prostate cancer.
Rhoden EL; Averbeck MA; Teloken PE
J Sex Med; 2008 Sep; 5(9):2202-8. PubMed ID: 18638000
[TBL] [Abstract][Full Text] [Related]
24. Testosterone and the Prostate.
Tan RB; Silberstein JL; Hellstrom WJ
Sex Med Rev; 2014 Oct; 2(3-4):112-120. PubMed ID: 27784562
[TBL] [Abstract][Full Text] [Related]
25. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
26. Late-onset hypogonadism: Prostate safety.
Miranda EP; Torres LO
Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383
[TBL] [Abstract][Full Text] [Related]
27. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
Park SG; Yeo JK; Cho DY; Park MG
Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
[TBL] [Abstract][Full Text] [Related]
28. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
[TBL] [Abstract][Full Text] [Related]
29. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
30. Testosterone Therapy: What We Have Learned From Trials.
Corona G; Torres LO; Maggi M
J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
[TBL] [Abstract][Full Text] [Related]
31. Should Men Eat More Plants? A Systematic Review of the Literature on the Effect of Plant-Forward Diets on Men's Health.
Feiertag N; Tawfik MM; Loloi J; Patel RD; Green B; Zhu M; Klyde D; Small AC; Watts KL
Urology; 2023 Jun; 176():7-15. PubMed ID: 36963667
[TBL] [Abstract][Full Text] [Related]
32. Late-life onset hypogonadism: a review.
Bassil N; Morley JE
Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
[TBL] [Abstract][Full Text] [Related]
33. Testosterone therapy for men at risk for or with history of prostate cancer.
Morgentaler A
Curr Treat Options Oncol; 2006 Sep; 7(5):363-9. PubMed ID: 16904053
[TBL] [Abstract][Full Text] [Related]
34. Testosterone replacement therapy: clinical considerations.
Luther PM; Spillers NJ; Talbot NC; Sinnathamby ES; Ellison D; Kelkar RA; Ahmadzadeh S; Shekoohi S; Kaye AD
Expert Opin Pharmacother; 2024; 25(1):25-35. PubMed ID: 38229462
[TBL] [Abstract][Full Text] [Related]
35. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
36. Testosterone and Benign Prostatic Hyperplasia.
Rastrelli G; Vignozzi L; Corona G; Maggi M
Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920
[TBL] [Abstract][Full Text] [Related]
37. Testosterone and men's quality of life.
Moncada I
Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553
[TBL] [Abstract][Full Text] [Related]
38. Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial.
Rastrelli G; Cipriani S; Lotti F; Cellai I; Comeglio P; Filippi S; Boddi V; Della Camera PA; Santi R; Boni L; Nesi G; Serni S; Gacci M; Maggi M; Vignozzi L
J Endocrinol Invest; 2022 Jul; 45(7):1413-1425. PubMed ID: 35298833
[TBL] [Abstract][Full Text] [Related]
39. Testosterone replacement therapy and prostate health.
Polackwich AS; Ostrowski KA; Hedges JC
Curr Urol Rep; 2012 Dec; 13(6):441-6. PubMed ID: 22927059
[TBL] [Abstract][Full Text] [Related]
40. Hypogonadism management and cardiovascular health.
Auerbach JM; Khera M
Postgrad Med; 2020 Dec; 132(sup4):35-41. PubMed ID: 32799602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
